Butterfly Equity-backed supplements brand MaryRuth Organics is likely to sell to a strategic for around 4x revenue or up to $1 billion, sources familiar with the situation tell Axios.
Why it matters: While CPG conglomerates are more selective about what they acquire, they are paying multiples of revenue for the targets they do find attractive.
